Detection of human immunodeficiency virus infection in the sputum of tuberculosis patients in South India

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 10, 2010, Pages 1288-1294

  Grandin, W ^a   Dev, A V ^b   Latha, A ^b   Armstrong, L ^b   Mathai, D ^b   John, K R ^b   Daley, Peter ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Enzyme immunoassay; HIV; India; Sputum; Tuberculosis

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; TUBERCULOSIS;

ADULT; FEMALE; HIV; HIV INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; INDIA; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; SPUTUM; TUBERCULOSIS;

EID: 77957069086     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Revised National Tuberculosis Control Program (RNTCP). TB India 2009: RNTCP status report. New Delhi, India: Ministry of Health and Family Welfare, 2009.
2. Agarwal S P, Chauhan L S. Tuberculosis control in India. New Delhi, India: Ministry of Health and Family Welfare, 2005.
3. Swaminathan S, Ramachandran R, Baskaran G, et al. Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 2000; 4: 839-844.
4. National AIDS Control Organization (NACO). Annual HIV sentinel surveillance country report: 2006. New Delhi, India: India Ministry of Health and Family Welfare, 2007.
5. Rajasekaran S, Lima A, Kamakshi S, et al. Trend of HIV infection in patients with tuberculosis in rural South India. Indian J Tuberc 2000; 47: 223-226. (Pubitemid 33208916)
6. Raizada N, Chauhan L S, Khera A, et al. HIV servoprevalence among tuberculosis patients in India, 2006-2007. PLoS One 2008; 3: e2970 (1-6).
7. Joint United Nations Programme on HIV/AIDS/World Health Organization Working Group on Global HIV/AIDS and STI Surveillance. Guidelines for conducting HIV sentinel sero-surveys among pregnant women and other groups. Geneva, Switzerland: WHO, 2003.
8. Orasure Techonologies Inc. Oraquick Advance rapid HIV-1/2 antibody test [package insert]. Bethlehem, PA, USA: Orasure Technologies Inc, 2005.
9. Talbot E A, Hone N M, Moffat H J, et al. The validity of HIV testing using sputum from suspected tuberculosis patients, Botswana, 2001. Int J Tuberc Lung Dis 2003; 7: 710-713.
10. Egwaga S M, Chonde T M, Matee M I, et al. Low specificity of HIV-testing on sputum specimens kept at ambient temperatures for 4 to 7 days: a blinded comparison. BMC Clin Pathol 2007; 7: 1-6.
11. Nelson L J, Talbot E A, Mwasekaga M J, et al. Anti-tuberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002. Lancet 2005; 366: 488-490.
12. Duffell E, Toskin I, Ghys P, et al. Guidelines for HIV surveillance among tuberculosis patients. 2nd ed. Geneva, Switzerland: World Health Organization, 2004.
13. Calypte Biomedical Corporation. Calypte 'Aware' HIV-1/2 OMT: a qualitative, visually read, in vitro immunoassay for the detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) in human oral mucosal transudate specimens [package insert]. Rockville, MD, USA: Calypte, 2005.
14. O'Connell R J, Merritt T M, Malia J A, et al. Performance of the Oraquick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol 2003; 41: 2153-2155.
15. Mishra D, Singh H P. Kuppuswamy's socio-economic status scale - a revision. Indian J Pediatr 2003; 70: 273-274.
16. Buderer N M. Statistical methodology: incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 1996; 3: 895-900.
17. Jones S R, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J 2003; 20: 453-458. (Pubitemid 37168224)
18. Carley S, Dosman S, Jones S R, Harrison M. Simple nomograms to calculate sample size in diagnostic studies. Emerg Med J 2005; 22: 180-181.
19. Banoo S, Bell D, Bossuyt P, et al; The TDR Diagnostics Evaluation Expert Panel. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol 2006; 1 (Suppl): S21-S33.
20. Ramachandran R, Datta M, Subramani R, Baskaran G, Paramasivan C N, Swaminathan S. Seroprevalence of human immunodefi ciency virus (HIV) infection among tuberculosis patients in Tamil Nadu. Indian J Med Res 2003; 118: 147-151. (Pubitemid 38008128)
21. Solomon S, Anuradha S, Rajasekaran S. Trend of HIV infection in patients with pulmonary tuberculosis in South India. Tubercle Lung Dis 1995; 76: 17-19.
22. Samuel N M, Alamelu C, Jagannath K, Rajan B. Detection of HIV infection in pulmonary tuberculosis patients. J Indian Med Assoc 1996; 94: 331-333.
23. Rao S R, Amarnath S K. HIV infections in Pondicherry. Indian J Med Microbiol 1996; 14: 43-47.
24. Vasadevaiah V. HIV infection among tuberculosis patients. I ndian J Tuberc 1997; 44: 97-98.
25. Bartlett R C. Medical microbiology: quality, cost, and clinical relevance. New York, NY, USA: John Wiley and Sons, 1974.
26. Vajpayee M, Kanswal S, Seth P, Wig N, Pandey R M. Tuberculosis infection in HIV-infected Indian patients. AIDS Patient Care STDS 2004; 18: 209-213. (Pubitemid 38552653)